Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networks [CrispR_FOXA1]. Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networks [CrispR_FOXA1]
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
RNA-seq Series of Bladder carcinoma cell lines RT112 and SD48 mutated for FOXA1 by CrispR. Overall design: RT112 and SD48 CRispR mutated for FOXA1 and controls.
创建时间：
2022-02-11
